Mivax Therapeutics, Inc.

CIK 2066303 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mivax Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jan 23, 2026D/A0002066303-26-000002
Jan 23, 2026D/A0002066303-26-000001
May 2, 2025D/A0002066303-25-000002
May 1, 2025D0002066303-25-000001